Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 6.

Journal Article

Heidenreich, A., O'Sullivan, J., Gillessen, S., Heinrich, D., Gratt, J., Levy, J., Miller, K., Nilson, S., Saad, F., Tucci, M., Wirth, M. and Carles, J. (2016). Effects of concomitant use of abiraterone and/or enzalutamide with radium-223 on safety and overall survival in metastatic castration resistant prostate cancer (mCRCP) patients treated in an international early access program (EAP). Oncol. Res. Treat., 39. S. 86 - 88. BASEL: KARGER. ISSN 2296-5262

Heidenreich, A., Saad, F., Caries, J., Gillessen, S., Heinrich, D., Gratt, J., Miller, K., Nilsson, S., O'Sullivan, J., Tucci, M. and Wirth, M. (2016). Effects of concomitant medication and baseline parameters on overall survival and safety in German metastatic castration-resistant prostate cancer patient subset treated with Radium-223 dichloride within the international early access program (iEAP). Oncol. Res. Treat., 39. S. 268 - 269. BASEL: KARGER. ISSN 2296-5262

Heinrich, D., Gillessen, S., Heidenreich, A., Keizman, D., O'Sullivan, J. M., Carles, J., Wirth, M., Miller, K., Procopio, G., Gratt, J., Seger-Van Tol, M., Nilsson, S. and Saad, F. (2016). Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP). Ann. Oncol., 27. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

Miller, K., Heinrich, D., O'Sullivan, J. M., Carles, J., Wirth, M., Nilsson, S., Huang, L., Kalinovsky, J., Heidenreich, A. and Saad, F. (2018). Radium-223 (Ra-223) therapy after abiraterone (Abi): Analysis of symptomatic skeletal events (SSEs) in an international early access program (iEAP) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). Ann. Oncol., 29. S. 287 - 288. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

Saad, F., Heidenreich, A., Heinrich, D., Keizman, D., O'Sullivan, J. M., Carles, J., Wirth, M., Miller, K., Gratt, J., Seger-Van Tol, M., Nilsson, S. and Gillessen, S. (2016). Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP). Ann. Oncol., 27. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

Zastrow, S., Saad, F., Heinrich, D., Gillessen, S., OSullivan, J., Carles, J., Miller, K., Huang, L., Van Tol, Seeger M., Nilsson, S. and Heidenreich, A. (2017). Radium-223 (Ra-223) in sequence or in concurrent use with abiraterone acetate (AA) or enzalutamide (E) in metastatic castration resistant prostate cancer (mCRPC) patients treated in an international early access program (iEAP). Oncol. Res. Treat., 40. S. 94 - 95. BASEL: KARGER. ISSN 2296-5262

This list was generated on Fri Mar 29 00:31:42 2024 CET.